Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 25th April 2022 Vol. No. 11; Issue No. 523

1. Puja R, Chakraborty A, Dutta S, Bose K (2022). Purification, characterization and functional site prediction of the vaccinia-related kinase 2A small transmembrane domain. MethodsX.

2. Ranjan N, Chopra S, Mangaj A, Rane P, Charnalia M, Kannan S, Dora T, Engineer R, Mahantshetty U, Gurram L, Mittal P, Ghosh J, Maheshwari A, Shylasree TS, Gupta S, Shrivastava SK (2022). Months and severity score (MOSES) in a phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials. eClinicalMedicine. 47: 101390.

3. Punatar S, Katti K, Rajamanickam D, Patil P, Dhakan C, Bagal B, Gokarn A, Bonda A, Nayak L, Gurjar M, Kannan S, Chiplunkar S, Gota V, Khattry N (2022). Role of curcumin in reducing toxicities associated with mucosal injury following melphalan-based conditioning in autologous transplant setting. Cell Transplantation.

4. Gandhi KA, Joshi A, Mehta P, Gurjar M, Rane P, Sharma J, Patil A, Nookala M, Noronha V, Prabhash K, Gota V (2022). Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer. Cancer Chemotherapy Pharmacology.

5. Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M, Gunasekera S, Ilbawi A, Kapambwe S, Kingham P, Kutluk T, Lamichhane N, Mutebi M, Orem J, Parham G, Ranganathan P, Sengar M, Sullivan R, Swaminathan S, Tannock IF, Tomar V, Vanderpuye V, Varghese C, Weiderpass E (2022). Priorities for cancer research in low- and middle-income countries: A global perspective. Nature Medicine. 28(4):649-657.

6. Poddar P, Maheshwari A, Shylasree TS, Yadav S, Kannan S, Ghosh J, Gullia S, Rath S, Chopra S, Gurram L, Gupta S (2022). Knowledge, attitudes and practices towards COVID-19: A cross-sectional survey. Indian Journal of Gynecologic Oncology. 20(2): 23.

Site of the Week

The Metabolomics Workbench Metabolite Database contains structures and annotations of biologically relevant metabolite.

desktop Image
Interesting Reads

Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y, Llorian Sopena M, MacRae J, Nye E, Howell M, Snijders AP, Prachalias A, Zen Y, Sarker D, Behrens A. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun. 13(1): 2070, 2022.

Legends of Science
Sudhir Kumar Sopory Sudhir Kumar Sopory

Sudhir Kunar Sopory obtained his Ph.D. from Delhi University in 1973. His notable contribution was to the mechanism of light and stress regulation of gene expression. Dr. Sopory has done significant work in the field of physiology of plant growth and development. His research has led to a better understanding of the mode of action of phytochrome and the possible involvement of calcium as a second messenger in higher plant cells. He is a member of several DBT, DST, CSIR, and UGC national committees. He was Vice Presient, INSA. Dr. Sopory was awarded the SS Bhatnagar award in 1987; ISCA Birbal Sahni Birth Centenary Award in 2006; Padma Shri in 2006. He was elected Fellow of the Indian Academy of Sciences, Bangalore; National Academy of Sciences, Allahabad; Academy of Sciences for the Developing World (TWAS).

Mathur Ramabhadrashastry Narasimha Murthy Mathur Ramabhadrashastry Narasimha Murthy

Mathur RN Murthy earned his Ph.D. from the Indian Institute of Science, Bangalore. Dr. Murthy and his group have worked out the three-dimensional structure of the Sesbania mosaic virus at 2.9 Å resolution by X-ray diffraction technique. His contributions have sharpened the understanding of how the complex molecular assemblies are put together in viruses. He is a Fellow of the Indian Academy of Sciences, Bangalore and National Academy of Sciences, Allahabad. Dr. Murthy is a recipient of the S S Bhatnagar Award in 1993; Rustom Choksi Award in 2002, and J C Bose Award in 2005.

Upcoming Events
4th International Conference on Cytokines in Cancer

19-24 May, 2022

At Chania, Crete, Greece.

EMBO Workshop -CD1/MR1-restricted T lymphocytes

22-26 May, 2022

At Gothenburg, Sweden.

Immune Responses in Cancer and Infection

15-17 June, 2022

At Lyon, France.

Do You Know?

In 2007, The FDA approved Nexavar (sorafenib) for primary liver cancer, making it the only drug approved for liver cancer.

back Image
Cancer News
Scientists identify new molecular strategies for tackling aggressive form of leukemia

20 April 2022, ScienceDaily

A discovery by researchers at the University of Sussex has the potential to benefit leukemia patients by opening up new treatment strategies for treating the disease...

New factors that can predict breast cancer recurrence defined

22 April 2022, EurekAlert

Stem cells are self-renewing and related to growth and development. Mammary stem cells are adult stem cells that can differentiate, or change function, into specialized mammary epithelial cells...

Study mines cancer genetics to help with targeted treatment.

23 April 2022, MedicalXpress

Scientists have analyzed the full genetic blueprints of more than 18,000 cancer samples, finding new patterns of mutations that could help doctors provide better, more personalized treatment.

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)